| Coral Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524506 |
NSE Symbol : - |
P/E(TTM) : 9.15 |
|
ISIN Demat : INE683E01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 49.45 |
|
Book Value(₹) : 596.89 |
Market Cap(₹Cr) : 161.49 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 19.03 | 18.82 | 28.13 | 22.99 | 32.23 | 31.66 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 19.03 | 18.82 | 28.13 | 22.99 | 32.23 | 31.66 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.03 | 2.05 | 2.48 | 2.52 | 2.54 | 1.56 |
| Total Income | 22.07 | 20.87 | 30.62 | 25.51 | 34.77 | 33.22 |
| Total Expenditure | 14.10 | 16.64 | 26.22 | 16.67 | 25.72 | 20.92 |
| PBIDT | 7.97 | 4.23 | 4.40 | 8.84 | 9.05 | 12.30 |
| Interest | 0.10 | 0.06 | 0.04 | 0.02 | 0.01 | 0.03 |
| PBDT | 7.87 | 4.17 | 4.36 | 8.82 | 9.04 | 12.27 |
| Depreciation | 0.45 | 0.45 | 0.51 | 0.50 | 0.51 | 0.49 |
| Tax | 1.59 | 1.15 | 1.10 | 2.15 | 2.13 | 2.95 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.01 | 0.01 | -0.08 | 0.02 | 0.02 | 0.02 |
| Reported Profit After Tax | 5.82 | 2.56 | 2.83 | 6.14 | 6.38 | 8.80 |
| Extra-ordinary Items | 0.25 | 0.00 | -0.55 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 5.57 | 2.56 | 3.38 | 6.14 | 6.38 | 8.80 |
| EPS (Unit Curr.) | 16.29 | 7.18 | 7.91 | 17.20 | 17.86 | 24.64 |
| EPS (Adj) (Unit Curr.) | 16.29 | 7.18 | 7.91 | 17.20 | 17.86 | 24.64 |
| Calculated EPS (Unit Curr.) | 16.29 | 7.18 | 7.91 | 17.20 | 17.86 | 24.64 |
| Calculated EPS (Adj) (Unit Curr.) | 16.29 | 7.18 | 7.91 | 17.20 | 17.86 | 24.64 |
| Calculated EPS (Ann.) (Unit Curr.) | 65.16 | 28.71 | 31.65 | 68.80 | 71.43 | 98.58 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 65.16 | 28.71 | 31.65 | 68.80 | 71.43 | 98.58 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 41.88 | 22.48 | 15.64 | 38.45 | 28.08 | 38.85 |
| PBDTM(%) | 41.36 | 22.16 | 15.50 | 38.36 | 28.05 | 38.76 |
| PATM(%) | 30.58 | 13.60 | 10.06 | 26.71 | 19.80 | 27.80 |